16ª Conferência Europeia sobre SIDA

A 16ª Conferência Europeia sobre SIDA terá lugar este mês.

A NAM tem a honra de ter sido selecionada como parceira oficial de notícias desta conferência pela European AIDS Clinical Society (EACS) e tal como anteriormente estará a trabalhar de forma empenhada para partilhar consigo as notícias da conferência.

Divulgaremos as investigações mais importantes apresentadas na conferência, publicaremos as notícias online e enviaremos via e-mail quatro boletins.

Pode subscrever para receber os nossos boletins sobre a conferência em português gratuitamente.


Sign up today

Sign up for our free email bulletins:

NAM's news coverage of the 16th European AIDS Conference has been supported by the European AIDS Clinical Society (EACS), and grants from Gilead Sciences Europe Ltd. and Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co. Inc. NAM's wider conference news reporting services have been supported by Janssen and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.